Researchers in Hungary investigated the efficacy of COVID-19 boosters in patients with autoimmune rheumatic and musculoskeletal diseases. They also studied whether a SARS-CoV-2 infection following a two-dose primary series increased antibody production by the immune system in lieu of a booster.
Read More »Researchers in British Columbia, Canada, conducted a retrospective cohort study with 1,105 adult patients to determine the risk of glomerular disease relapse following COVID-19 vaccination.
Read More »A survey-based study analyzed vaccination reactions and disease deterioration after SARS-CoV-2 vaccination among more than 6,000 MS patients in Germany and the United Kingdom.
Read More »A new study investigated how effective a two-dose SARS-CoV-2 vaccine regimen is for patients receiving Rituximab. Researchers measured the humoral and cellular immune responses, which correlate to antibody and T-cell production, respectively.
Read More »